Background: Stanniocalcin 2 (STC2) expression is upregulated under multiple stress conditions including hypoxia, nutrient starvation and radiation. Overexpression of STC2 correlates with tumor progression and poor prognosis. Purpose: We previously demonstrated that overexpression of STC2 in nasopharyngeal carcinomas (NPC) positively correlates with radiation resistance and tumor metastasis, two major clinical obstacles to the improvement of NPC management. However, it remains elusive whether STC2 expression is a critical contributing factor for post-radiation survival and metastasis of NPC cells. Materials and methods: Using the radiation resistant CNE2 cell line as a model, we examined the importance of STC2 expression for post-radiation survival, migration and invasion. Here, we report the establishment of STC2 knockout lines (CNE2-STC2-KO) using the CRISPR/Cas9-based genome editing technique. Results: Compared with the parental line, STC2-KO cells showed similar proliferation and morphology in normal culture conditions, and loss of STC2 did not compromise the cell tumorigenicity in nude mice model. However, STC2-KO lines demonstrated increased sensitivity to X-radiation under either normoxic or hypoxic conditions. Particularly, upon X-radiation, parental CNE2 cells only slightly whereas STC2-KO cells remarkably decreased the migration and invasion ability. Cell cycle analysis revealed that loss of STC2 accumulated cells in G 1 and G 2 /M phases but decreased S-population. Conclusion: These data indicate that the expression of STC2, which can be stimulated by metabolic or therapeutic stresses, is one important factor to promote survival and metastasis of post-radiation NPC cells. Therefore, targeting STC2 or relative downstream pathways may provide novel strategies to overcome radiation resistance and metastasis of NPC.
Introduction
NPC is the most common type of cancer among all head and neck malignancy in South-East Asia. Currently, the standard treatment for NPC is radiotherapy alone or in combination with chemotherapy. Radiation resistance and post-radiation metastasis are two major leading causes of treatment failure. Therefore, how to overcome radiation resistance and post-radiation metastasis of NPC remains an important question to be addressed.
Human stanniocalcin 2 (STC2) is a glycoprotein of 302-amino acids, with 34% identity to its homolog STC1, the prototype stanniocalcin initially identified from bony fish where it regulates calcium homeostasis in fish living in freshwater.
1,2 Accordingly, human stanniocalcins were initially proposed to regulate mineral metabolism. 3, 4 In normal human tissues, STC1 and STC2 show tissuespecific expression patterns. STC2 is highly expressed in selected tissues, particularly in smooth muscle and cardiac muscle, indicating a tissue-specific, conditionally required role of STC2 for normal cell physiology. By analyzing archived nasopharyngeal carcinoma samples and relative clinicopathological data, we previously found that STC2 overexpression correlated with radiation resistance, recurrence and metastasis in NPC. 7 Consistently, increased STC2 levels correlate with invasiveness, metastasis and poor prognosis in ovarian cancer, 8 breast cancers, 9 neuroblastoma, 10 prostate cancer, 11 esophageal squamous cell carcinoma (ESCC), 12 gastric cancer, 13 lung cancers, 14 colorectal cancer 15 and renal cell carcinoma (RCC). 16 However, the importance of STC2 in promoting cancer invasiveness and metastasis remains unclear. Particularly, it remains unknown whether STC2 expression is important for radiation resistance and post-radiation metastasis of NPC. In addition to NPC, STC2 overexpression has been observed in many other human tumors, including breast cancer, 17, 18 prostate cancer, 11 ESCC, 12 gastric cancer, 13 colorectal cancer, 15 RCC 16 and neuroblastoma. 10 While the molecular mechanisms underlying its regulation remains elusive, hypoxia has been reported to upregulate STC2 transcription through hypoxia-inducible factor-1, a transcription factor stabilized and activated by hypoxia and other oncogenic pathways, 8, 19 indicating tumor-specific microenvironment is a contributing factor to STC2 upregulation. In addition, STC1 was reported to be a negative indicator of prognosis of certain types of cancers. 20 We hypothesize that STC2 upregulation plays a critical role in mediating radiation resistance and metastasis of NPC. Taking radiation resistant CNE2 line as a model and using CRISPR/Cas9-based genome editing technology, we established STC2 knockout CNE2 lines (CNE2-STC2-KO), and thereafter investigated the potential effects of STC2 knockout on CNE2 cells response to X-radiation. We found that loss of STC2 compromised clonogenic ability post-radiation. Particularly, STC2-KO cells demonstrated reduced invasion and migration ability post-radiation comparing to the parental cells. Cell cycle analysis revealed that loss of STC2 accumulated cells in G 1 and G 2 /M phases, consistent with increased DNA damage and cytotoxicity. Taken together, these data indicate that STC2 expression, which can be stimulated by either metabolic or therapeutic stresses, is one important factor to promote NPC cell survival and metastasis post-radiation.
Materials and methods

Ethical statement
This study was approved by the Ethical Review Committee of Fujian Cancer Hospital (approval no. K201412). The animal experiment was performed in strict accordance with the protocol (SYXK(FJ)2013-004) and guidelines from the Institutional Animal Care and Use Committee at the Fujian Cancer Hospital.
Immunohistochemistry
Paraffin blocks that contained sufficient formalin-fixed tumor specimens were cut into 3 μm sections and mounted on silane-coated slides for immunohistochemical staining analysis. Sections were deparaffinized with dimethylbenzene and rehydrated consecutively using sequential ethanol (100%, 95%, 90%, 85%, 80% and 75%). Antigen retrieval was done in 0.01 M sodium citrate buffer (121°C for 2 mins, pH 6.0), and endogenous peroxidase was blocked by incubating slides in 3% H 2 O 2 for 10 mins at room temperature. The sections were then washed in PBS and incubated with anti-STC2 (1:100 dilution, Abcam, USA) at 4°C for 12 hrs. Subsequently, sections were washed three times in PBS and incubated with the horseradish peroxidase (HRP)-conjugated secondary antibody for 30 mins at room temperature. Signals were detected using DAB substrate (Maixin Co., Fuzhou, People's Republic of China). All slides were counterstained with 20% hematoxylin, dehydrated and mounted. Slides stained with antibody solution buffer were used as negative controls.
Cell lines and cell culture
Human NPC cell line CNE-2 was obtained from the Cell Bank of Chinese Academy of Sciences (Beijing, People's Republic of China). CNE-2 cells were cultured in RPMI-1640 culture medium supplemented with 10% new-born calf serum, 100 U/mL penicillin (Sigma-Aldrich) and 100 μg/mL streptomycin (Sigma-Aldrich) at 37°C in waterjacket incubator with 5% CO 2 . RPMI-1640 was purchased from Hyclone (SH30809.01, USA). Trypsin was bought from Amresco (0258-25G, USA 
Hypoxia and glucose starvation
Cells were flushed with a gas mixture of 1% O 2 , 5% CO 2 , and balanced N 2 in hypoxia work stations (3131, Thermo scientific, USA). Normal culture media contain 25 mM glucose, while for glucose starvation, medium with 2.5 mM glucose was used. 
RNA extraction and qRT-PCR
Radiation treatment of cancer cells
Cancer cell radiation was performed at room temperature with an ELEKTA accelerator (6MV X, Sweden) with a radiation field of 30 cm×30 cm. Cells were radiated at a distance of 100 cm, with a radiation strength of 285 cGy/min. For radiation sensitivity assays, cells were cultured in a water-jacketed cell culture incubator until reaching 80% confluence, then cells were digested with 0.25% trypsin to create single cell suspension and re-seeded into 25-T flasks. When cell density reached 40-50%, the flasks were divided into four groups randomly. Two groups were kept in 21% O 2 while the other two groups were cultured under 1% O 2 . After reaching about 80% confluence, cells were exposed to 4 Gy X radiation, followed by other studies.
Western blotting analyses
Anti-STC2 antibody (Ab63057) was purchased from Abcam (USA). Anti-HIF-1α antibody was purchased from Cell Signaling Technology (USA). Anti-α-tubulin and all horseradish peroxidase-coupled secondary antibodies were purchased from Thermo Scientific or Sigma (USA).
Cultured cells were used to prepare total cell lysis following the previously published procedure. After 12,000 g centrifugation at 4°C for 10 mins, supernatant was collected and protein concentration was determined using Pierce TM BCA Protein Assay Kit (Thermo scientific, USA). Same amount of protein samples were separated through electrophoresis in 10% SDS-PAGE, followed by electro-transferring to PVDF membrane. Then, the membrane was blocked with 3% non-fat dry milk overnight and washed with TTBS (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.2), three times prior to incubation with primary antibody for 4 hrs. After three washes with TTBS, the membrane was incubated with HRP-labelled secondary antibody for 3 hrs. After the washes with TTBS, the membrane was finally developed with ECL kit, and imaged with a multi-functional imaging system (4000 MM PRO, Carestream, Canada).
Trypan blue staining
Cell survival rates were estimated based on cell counting after Trypan Blue staining (Amresco, USA). Briefly, CNE-2, CNE2-STC2-KOA and CNE2-STC2-KOB cells were cultured under either normoxic or hypoxic conditions overnight. After radiation and re-culturing, cells were digested with 0.25% trypsin to obtain single cell suspension. 0.4% trypan blue was added to a final concentration of 0.04%. Dead and living cells were separately counted using a light microscope and hematocytometers. The cell survival rates were calculated as in the following: Survival rate (%)=(living cell number/total cell number)×100%.
Post-radiation clonogenic assays
Cells were seeded in 6-well culture plates. Radiation was performed as described above. A single dose of 0, 2, 4, 6, 8 and 10 Gy for cell numbers of 100, 200, 400, 800, 1,600 and 3,200 cells/well, respectively. After radiation, cells were cultured for 14 days with a medium change every other day. Cell culture dishes were stained with crystal violet and examined under light microscopy. Clusters of ≥50 cells were considered valid colonies which were counted. Survival fraction (SF) was calculated based on the following equations: 
Flow cytometric analysis of apoptosis 
Cell cycle analysis
CNE2 and CNE2-STC2-KO cells at approximately 60% confluence were exposed to X-radiation at doses of 0 and 4 Gy, respectively. Then, cells were digested with 0.25% trypsin in order to prepare single cell suspension. After washing with PBS, cells were stained with the cell cycle detection kit (BD Biosciences, San Diego, CA, USA) following the manufacturer's instructions, and analyzed with an FACSCanto TM II flow Cytometer (BD Biosciences; San Jose, CA, USA). All analyses were repeated in triplicate.
Cell migration assays
The Cell Culture Inserts (Millicell) were purchased from Millipore (CAT NO: PIEP12R48, Switzerland). Cell migration assays were performed as described previously. 21 The lower chamber surface of the Inserts was evenly coated with 10 μL fibronectin (1 mg/mL). The coated inserts were placed in 24-well cell culture plates and placed in 37°C incubator for 4 h prior to assays. Single cell suspension was diluted with serum-free RPMI-1640 media to a final density of 2×10 5 cells/ mL. 100 μL cell suspension was added into the upper chambers of the inserts, while 600 μL RPMI-1640 containing 20% calf serum were added into the lower chamber. The set-up was cultured in a water-jacketed cell culture incubator for 24 hrs. After removal of non-migrated cells on the upper chamber side, the inserts were fixed in 100% methanol for 30 mins, dried and stained with 0.1% Crystal Violet Staining Solution (cat #: C0121, Beyotime, People's Republic of China) for 15 min. After a thorough wash with water, the insert membranes were observed under a microscopy (200 ×). Total numbers of migrating cells of each optic field (up, down, left, right, center)
were obtained and recorded. The mean of migrated cells was calculated based on three independent experiments.
Cell invasion assays
Matrigel was purchased from CORNING (cat #: 356,234, Bedford, MA, USA). Cell invasion assays were performed as described previously. 21 The Matrigel was dissolved and mixed with serum-free media at 4°C. Into each of the upper chamber of the Cell Culture Inserts, 100 μL Matrigel-mix were added. The hanging cell culture was then incubated in a cell culture incubator for 2 hrs for Matrigel to cure. Single cell suspension was diluted with serum-free RPMI-1640 media to final density of 2×10 5 cells/mL. 100 μL cell suspension was added into the upper chamber of the Inserts, with 600 μL RPMI-1640 containing 20% calf serum in the lower chamber. The setup was cultured in a water-jacketed cell culture incubator for 48 hrs. After removal of cells and Matrigel on the upper chamber side, the insert membranes were processed as described in cell migration assays.
Statistical analysis
SPSS17.0 was used for statistical analysis. Data from different groups were subjected to Student's t-test and One-way ANOVA. P<0.05 was set as significant difference.
Results
STC2 expression is upregulated by metabolic stress commonly existing in solid tumors
Previously, we showed that STC2 overexpression positively associates with radiation resistance and metastasis in NPC patients; however, potential causes that trigger STC2 overexpression in NPC remain unclear. Hypoxia was reported to upregulate STC2 expression in other tumor models, and both hypoxia and glucose starvation are common consequences of insufficient angiogenesis in rapid growing solid tumors. Using unbiased genome-wide gene expression profiling of hepatocellular carcinoma cells, we identified STC2 as one of those genes commonly upregulated by metabolic stress, such as hypoxia, glucose depletion or glutamine depletion (collectively, nutrient depletion). To investigate if common metabolic stress is sufficient to trigger STC2 expression in CNE2 cells, we exposed cultured CNE2 cells under hypoxia or combination of hypoxia and glucose starvation conditions. Western blotting analyses and qPCR indicate that either hypoxia or combination of hypoxia and glucose starvation is sufficient to upregulate STC2 expression (P<0.01, Figure 1A and B; P<0.05, Figure 1C ), suggesting metabolic stresses commonly associated with solid tumor microenvironment could be a cause of STC2 upregulation in NPC.
Establishment and characterization of CNE2-STC2-KO lines
To evaluate the importance of STC2 overexpression in NPC cells, we used the CRISPR/Cas9-based genome editing to knock out STC2 in CNE2 cells. Using an online tool, we designed a gRNA sequence to target nucleotides 803-823 (GenBank: BT019591.1). Oligos of both strands were designed and synthesized ( Figure 2A ). After annealing, the double-stranded DNA fragment with designed compatible sticky ends were inserted into pX330 to express the gRNA, along with tracRNA for Cas9 recognition. After G418 selection and expanding cell clones, we screen the cell clones by Western blotting analyses to check the knockout effects ( Figure 2B ). Clone#1 and #3 in Figure 2B showed overt knockout effects (P<0.001), so they were further expanded and designated as CNE2-STC2-KOA and CNE2-STC2-KOB, respectively. Next, we cultured these two KO clones along with parental CNE2 under normoxic and hypoxic conditions. We observed that hypoxia-mediated upregulation of STC2 was apparent in the parental CNE2 line whereas CNE2-STC2-KOA or KOB ones showed residual levels of STC2 under hypoxia condition ( Figure 2C ). To determine the effect of loss of STC2 on general cell morphology, we used limiting dilution to culture both parental CNE2 and KO lines to observe cell morphology and colony formation in rapid clonal proliferation. As shown in Figure 2D , loss of STC2 did not alter the general morphology of CNE2 cells. To address if loss of STC2 impairs the tumorigenicity of CNE2, we prepared single cell suspension in serum-free medium, and subcutaneously injected these cells into three nude mice for each cell line and housed the mice up to 8 weeks. We observed that both CNE2 and KO lines generated tumor xenografts, which were confirmed by pathologists, and STC2 expression status was confirmed by immunohistochemical staining ( Figure 2E ). Taken together, these data indicate that we have established CNE2-STC2-KO lines, which maintain morphology in regular culture and tumorigenicity in nude mice similar to parental CNE2 cells. The CNE2 and genetically matched CNE2 STC2 KO lines provide a model system to further investigate the importance of STC2 in radiation resistance and post-radiation metastasis.
Loss of STC2 enhances cell death postradiation
To determine the importance of STC2 in cancer cell survival post-radiation, we cultured CNE2 and the two STC2-KO lines in either normoxic or hypoxic condition. Without radiation, CNE2-STC2-KOA and CNE2-STC2-KOB maintain survival rates <95%, which shows no significant difference from CNE2 (P>0.05) under either normoxic or hypoxic condition. Under normoxic conditions, radiation treatment reduced the survival rate of CNE2 cells to 92.24 ±3.76% (Figure 3) 
Loss of STC2 impairs post-radiation clonogenic ability of CNE2 cells
Radiation-resistant CNE2 cells have strong post-radiation clonogenic ability. To further substantiate the importance of STC2 in CNE2 radiation resistance, we performed clonogenic assays under both normoxic and hypoxic conditions ( Figure  4A and C). The dose-survival curves were obtained under both normal and hypoxic conditions ( Figure 4B and D) . From these curves, we observed that after exposure to the same doses of X-radiation, CNE2- Finally, potential role of STC2 in protecting NPC cells from radiation-caused apoptosis was analyzed. Six hours after exposure to 4 Gy X-radiation, cells were stained and analyzed for apoptosis ( Figure 5A ) and the results are summarized in Figure 5B . Loss of STC2 in CNE2-STC2-KOA and CNE2-STC2-KOB cells resulted in higher rates of apoptosis than CNE2 after radiation exposure (P<0.05 for normoxia; P<0.05 for 1%O 2 ). Taken together, these data indicate that loss of STC2 significantly increases the radiation-caused apoptosis of CNE2 cells, particularly under hypoxic conditions. 
Loss of STC2 increase cells at G 1 and G 2 / M phases post-radiation
Radiation causes DNA damage that in turn usually triggers a G 2 /M arrest mediated by ATR/ATM-p53 pathways. [22] [23] [24] Therefore, we next assessed the effects of STC2 loss on the cell cycle progression post-radiation ( Figure 6 ). We found that without radiation exposure, CNE2, CNE2-STC2-KOA and CNE2 STC2-KOB have a similar percentage of cells in G 2 /M phases. When analyzed 6-hr post-radiation, CNE2-STC2-KOA and CNE2-STC2-KOB cells showed a significantly increased percentage of cells in G 1 and G 2 /M phases (P<0.05 for G 1 ; P<0.001 for G 2 /M, Figure 6A and B), but a decrease in S-phase compared with control cells (P<0.001, Figure 6A and B). Similar results were observed when CNE2 cells were comparably studied with the STC2-KO lines under hypoxic conditions (P<0.05 for G 1 ; P<0.001 for G 2 /M and S, Figure 6A and C). These data strongly indicate 
Loss of STC2 undermines post-radiation migration and invasion of CNE2
Cancer cell migration and invasion play key roles in tumor metastasis. Post-radiation recurrence and metastasis are the major causes of therapeutic failure in NPC management. To investigate the effects of STC2 on post-radiation metastasis,
we compared the post-radiation migration ability of CNE2 and CNE2-STC2-KO lines using the Transwell culture assays ( Figure 7A and B) . We found that without radiation, CNE2, CNE2-STC2-KOA and CNE2-STC2-KOB had similar migration ability. Hypoxia alone did not alter the migration ability of CNE2 (P>0.05). We next exposed cells to 4 Gy X-radiation and continued the culture for another 6 hrs. Then, we prepared single cell suspensions and seeded about 2×10 4 live cells in each Transwell to test the postradiation migration abilities. We found that 4 Gy X-radiation only slightly impaired CNE2 migration ability, whereas it significantly suppressed the migration of both CNE2- 
STC2-KOA and CNE2-STC2-KOB cells under both normoxic and hypoxic conditions (P<0.01).
We next investigated the effects of STC2 knockout on post-radiation invasion ability of NPC cells using the standard Matrigel assays ( Figure 7C and D) . When cells were studied without radiation, CNE2, CNE2-STC2-KOA and CNE2-STC2-KOB showed similar invasion ability under both normoxic and hypoxic conditions. When 2×10 4 irradiated cells were tested under normoxic conditions, CNE2 cells resulted in 49±3 cells invaded through the Matrigel; whereas CNE2-STC2-KOA and CNE2-STC2-KOB resulted in significantly reduced invasion (26±3, P<0.01; and 23±2, P<0.01, respectively). Under hypoxic conditions, radiated CNE2 resulted in 51±3 cells invaded the Matrigel, whereas loss of STC2 dramatically reduced the post-radiation invading cells to 5±2 and 4±2, as shown in CNE2-STC2-KOA and CNE2-STC2-KOB, respectively (in both cases, P<0.01). Taken together, these data indicate that under normal culture conditions STC2 expression does not alter NPC migration or invasion significantly, whereas it plays a critical role in maintaining the migration and invasion ability of NPC cells exposed to radiation.
Discussion
In this study, we determined if STC2 expression is required for the development of radiation resistance and metastasis of NPC. Using CNE2-STC2-KO cell lines, we demonstrated that loss of STC2 increases radiation sensitivity of NPC cells under both normoxic and hypoxic conditions. Cell cycle analysis reveals that loss of STC2 significantly accumulates cells in G 1 and G 2 /M phases, consistent with enhanced DNA damage and cytotoxicity post-radiation. These data strongly indicate that STC2 expression, which can be stimulated by metabolic stress commonly occurring in solid tumors, may contribute to maintaining the survival of NPC cells post-radiation. Importantly, we show that although loss of STC2 does not impair the tumorigenicity of CNE2 cells, it significantly decreases the invasion and migration ability post-radiation, suggesting STC2 expression may be a promoting factor for NPC metastasis in vivo. STC2 expression has been reported to be upregulated under various stress conditions, including metabolic and therapeutic stresses. Molecular oxygen, glutamine and glucose represent three major nutrients for cells undergoing rapid proliferation in order to support active biosynthesis. [25] [26] [27] A defective blood supply is a common feature of solid tumors, which leads to hypoxia, low glutamine and low glucose conditions in the tumor microenvironment, which may, in turn, upregulate STC2 expression. [28] [29] [30] Hypoxia was previously reported to upregulate STC2, 8, 31, 32 we also found that STC2 was strongly upregulated by either glutamine or glucose starvation in hepatocellular carcinoma cells. 33 In this study, we confirmed that hypoxia and glucose starvation upregulate STC2 expression in NPC cells. In addition, STC2 has been reported to be upregulated under other stress conditions, including radiation 34 and ER stress. 35 Therefore, STC2 is likely a gene involved in common stress response, which in turn protects cells from apoptosis induced by stress conditions including radiation. Since it is upregulated by multiple stress conditions, nutrient-deprivation stimulated STC2 expression is likely a critical player in tumor cells' resistance to chemotherapy and radiotherapy. Therefore, targeting STC2 in combination with other therapeutic regimens may have a potential application in the improvement of therapeutic efficiency.
In addition to promoting cell survival, STC2 overexpression has been associated with enhanced cell migration in other cell models. It has been proposed that STC2 facilitates tumor cell migration through epithelialmesenchymal transition and the upregulation of MMP-2 and MMP-9 under hypoxic conditions. 8, 10 Consistent with these previous studies, we found that loss of STC2 impaired NPC cell invasion and migration post-radiation. Therefore, STC2-facilitated post-radiation invasion and migration of NPC cells may contribute to the high risk of NPC metastasis and poor overall survival rates, further supporting the notion that STC2 overexpression is a predictive marker for poor prognosis of NPC. Cell cycle analysis reveals that loss of STC2 significantly accumulates radiated cells at G 1 and G 2 /M phases. It is well known that DNA damage triggers G 1 arrest and G 2 /M arrest to allow cells to repair damaged DNA and chromosomes, which involves complicated protein phosphorylation-mediated processes including ATM/ATR sensing and p53 activation. [22] [23] [24] When severe DNA damage overwhelms the cells' ability to repair, apoptosis will be triggered. It has been reported that DNA damage response plays a key role in radiation resistance of glioma stem cells. 36 Accordingly, DNA damage response has been considered an important barrier for anti-cancer therapies. 37 Our findings imply that STC2 expression may facilitate DNA repair processes, which may be an important component of the DNA damage response. Mechanistically, STC1 identified from bony fish functions as a hormone, which regulates calcium and phosphate metabolism in response to variation of calcium concentrations in living water environment. In mammalian cells, STC2 can be either intracellular protein or secreted, and the intracellular portion of STC2 is mainly localized on the ER membrane. As such, STC2 has been proposed to regulate the function of STIM1, an ER calcium sensor which promotes extracellular Ca 2+ entry upon ER Ca 2+ storage decline. 5, 6 However, considering STC is conserved in many distant species, its role in cell physiology of mammals is apparently more complicated. In human cells, STC1 seems to act the conserved function to control the organismal level homeostasis of calcium and phosphate metabolism, whereas STC2 has been found to regulate cellular level calcium signaling pathways which in turn control a variety of physiological and pathological processes. 6 Calcium may serve as a signaling molecule for various extracellular stimuli and regulates a flock of cellular activities. 38, 39 Particularly, the role of STC2 in regulating cell proliferation and survival also has been studied with different cell lines. Collectively, it is likely that STC2 promotes cell survival through intracellular calcium-mediated pathways. Considering the role of STC2 in promoting cell survival and radiation resistance, it would be intriguing to further investigate how STC2 overexpression may affect the calcium signaling pathways, which may provide a mechanistic link between various stress conditions, including therapeutic stresses, to DNA repair, cell survival and migration.
Conclusion
In conclusion, our findings indicate that STC2 expression is critical to radiation resistance of CNE2. While loss of STC2 function does not impair the tumorigenicity of CNE2, stress-triggered STC2 expression is required to promote post-radiation survival, clonogenic ability, invasiveness and migration of CNE2 cells. Therefore, targeting STC2 function may provide a novel strategy to effectively overcome radiation resistance and prevent post-radiation metastasis of NPC. However, this remains a hypothesis to be validated by in vivo studies and corroborated by a thorough mechanistic understanding.
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